On Tuesday, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) opened higher 6.09% from the last session, before settling in for the closing price of $3.12. Price fluctuations for MRVI have ranged from $1.66 to $8.53 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -64.27% over the last five years. Company’s average yearly earnings per share was noted -214.93% at the time writing. With a float of $105.17 million, this company’s outstanding shares have now reached $144.62 million.
The firm has a total of 570 workers. Let’s measure their productivity.
Maravai LifeSciences Holdings Inc (MRVI) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Maravai LifeSciences Holdings Inc is 27.30%, while institutional ownership is 77.02%. The most recent insider transaction that took place on Jan 31 ’25, was worth 125,750. In this transaction General Counsel of this company sold 25,000 shares at a rate of $5.03, taking the stock ownership to the 167,618 shares. Before that another transaction happened on Jan 31 ’25, when Company’s Officer proposed sale 25,000 for $5.03, making the entire transaction worth $125,750.
Maravai LifeSciences Holdings Inc (MRVI) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.02 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.01) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -214.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.65% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
Check out the current performance indicators for Maravai LifeSciences Holdings Inc (MRVI). In the past quarter, the stock posted a quick ratio of 4.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Analysing the last 5-days average volume posted by the [Maravai LifeSciences Holdings Inc, MRVI], we can find that recorded value of 1.95 million was lower than the volume posted last year of 2.22 million. As of the previous 9 days, the stock’s Stochastic %D was 77.77%.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 93.79%, which indicates a significant increase from 88.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.58, while its 200-day Moving Average is $2.98. Now, the first resistance to watch is $3.43. This is followed by the second major resistance level at $3.56. The third major resistance level sits at $3.71. If the price goes on to break the first support level at $3.15, it is likely to go to the next support level at $3.00. Should the price break the second support level, the third support level stands at $2.87.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
There are currently 255,362K shares outstanding in the company with a market cap of 845.25 million. Presently, the company’s annual sales total 259,190 K according to its annual income of -144,850 K. Last quarter, the company’s sales amounted to 47,400 K and its income totaled -39,590 K.
